Choi Yujin, Kim Yunna, Kwon Ojin, Chung Sun-Yong, Cho Seung-Hun
Clinical Medicine Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea.
Department of Neuropsychiatry, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.
Integr Med Res. 2021 Jun;10(2):100453. doi: 10.1016/j.imr.2020.100453. Epub 2020 Jun 20.
Huanglian-jie-du (HJD) granule, which is composed of representative "heat-clearing" herbs has been used for . is a culture-bound syndrome in Korea, characterized by distinct somatic symptoms such as chest congestion and heat sensation resulting from suppressed anger. We investigated the effect of HJD in patients with .
Forty-four patients with were recruited, and HJD or placebo granules were administered orally three times daily for seven days. The two primary outcomes were somatic symptoms, which were measured by Patient Health Questionnaire of physical symptoms (PHQ-15), and insomnia, which was measured by Insomnia Severity Index (ISI) at post-treatment.
Between July 10 and October 31, 2017, 44 patients with (mean age 36.68 years; and 38 female) were randomly assigned to HJD (n = 22) or placebo (n = 22) group. After administration of HJD or placebo granule for seven days, ISI score was lower in the HJD group compared to placebo group at post-treatment (adjusted mean difference -2.56 [95% CI -4.72 to -0.39], p = 0.0208). Meanwhile, there was no difference in PHQ-15 score between HJD group and placebo group at post-treatment (adjusted mean difference -0.50 [95% CI: -3.02-4.02], p = 0.7812).
Our results suggest that the administration of HJD granule has a potential to improve insomnia in patients. Effect of HJD granule for general somatic symptoms in byung patients is unclear, and further researches are needed.
Clinical Research Information Service, KCT0002379.
黄连解毒颗粒由具有代表性的“清热”草药组成,一直用于…… 是韩国一种与文化相关的综合征,其特征是由愤怒抑制引起的明显躯体症状,如胸部闷塞和发热感。我们研究了黄连解毒颗粒对…… 患者的影响。
招募了44例…… 患者,黄连解毒颗粒或安慰剂颗粒每日口服3次,共7天。两个主要结局指标为躯体症状,通过患者躯体症状健康问卷(PHQ - 15)进行测量;以及失眠,通过治疗后失眠严重程度指数(ISI)进行测量。
2017年7月10日至10月31日,44例…… 患者(平均年龄36.68岁;女性38例)被随机分为黄连解毒颗粒组(n = 22)或安慰剂组(n = 22)。给予黄连解毒颗粒或安慰剂颗粒7天后,治疗后黄连解毒颗粒组的ISI评分低于安慰剂组(调整后平均差值 - 2.56 [95%置信区间 - 4.72至 - 0.39],p = 0.0208)。同时,治疗后黄连解毒颗粒组和安慰剂组的PHQ - 15评分无差异(调整后平均差值 - 0.50 [95%置信区间: - 3.02 - 4.02],p = 0.7812)。
我们的结果表明,给予黄连解毒颗粒有可能改善…… 患者的失眠。黄连解毒颗粒对…… 患者一般躯体症状的影响尚不清楚,需要进一步研究。
韩国临床研究信息服务中心,KCT0002379 。
需注意,原文中存在部分未明确表述的内容(用省略号代替),可能会影响对完整研究内容的准确理解。